These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 28795329

  • 1. Copeptin as a marker of an altered CRH axis in pituitary disease.
    Lewandowski KC, Lewiński A, Skowrońska-Jóźwiak E, Malicka K, Horzelski W, Brabant G.
    Endocrine; 2017 Sep; 57(3):474-480. PubMed ID: 28795329
    [Abstract] [Full Text] [Related]

  • 2. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress.
    Kacheva S, Kolk K, Morgenthaler NG, Brabant G, Karges W.
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):570-6. PubMed ID: 25200793
    [Abstract] [Full Text] [Related]

  • 3. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [Abstract] [Full Text] [Related]

  • 4. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
    Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.
    Stress; 2019 Jan; 22(1):93-102. PubMed ID: 30369292
    [Abstract] [Full Text] [Related]

  • 5. The stress hormone copeptin: a new prognostic biomarker in acute illness.
    Katan M, Christ-Crain M.
    Swiss Med Wkly; 2010 Jan; 140():w13101. PubMed ID: 20872295
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of the classic ovine corticotrophin releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin.
    Favrod-Coune C, Raux-Demay MC, Proeschel MF, Bertagna X, Girard F, Luton JP.
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):405-10. PubMed ID: 7686454
    [Abstract] [Full Text] [Related]

  • 7. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E, Maccagno B, Ramunni J, Di Vito L, Broglio F, Deghenghi R, Camanni F, Ghigo E.
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [Abstract] [Full Text] [Related]

  • 8. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
    Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, Bloom SR.
    Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
    [Abstract] [Full Text] [Related]

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [Abstract] [Full Text] [Related]

  • 10. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 11. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
    Korbonits M, Kaltsas G, Perry LA, Putignano P, Grossman AB, Besser GM, Trainer PJ.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2489-95. PubMed ID: 10404825
    [Abstract] [Full Text] [Related]

  • 12. Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency.
    Bologna K, Cesana-Nigro N, Refardt J, Imber C, Vogt DR, Christ-Crain M, Winzeler B.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32236441
    [Abstract] [Full Text] [Related]

  • 13. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 01; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 14. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul 01; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.
    Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM, Grossman A.
    J Endocrinol; 1991 Oct 01; 131(1):163-7. PubMed ID: 1660514
    [Abstract] [Full Text] [Related]

  • 16. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C, Iyer V, Bhatnagar S.
    J Neuroendocrinol; 2007 Mar 01; 19(3):198-207. PubMed ID: 17280593
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of the pituitary adrenocortical system in man by cerulein, a cholecystokinin-8-like peptide.
    Späth-Schwalbe E, Piroth L, Pietrowsky R, Born J, Fehm HL.
    Clin Physiol Biochem; 1988 Mar 01; 6(6):316-20. PubMed ID: 2850129
    [Abstract] [Full Text] [Related]

  • 18. The acute effect of lowering plasma cortisol on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin as revealed by intensive sampling of pituitary venous blood in the normal horse.
    Alexander SL, Irvine CH, Livesey JH, Donald RA.
    Endocrinology; 1993 Aug 01; 133(2):860-6. PubMed ID: 8393777
    [Abstract] [Full Text] [Related]

  • 19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Aug 01; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin releasing hormone stimulation test and nocturnal cortisol levels in normal children.
    Dahl RE, Siegel SF, Williamson DE, Lee PA, Perel J, Birmaher B, Ryan ND.
    Pediatr Res; 1992 Jul 01; 32(1):64-8. PubMed ID: 1321974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.